BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Talmon M, Chaudhari RD, Suryavanshi H, Chowdhury N, Quaregna M, Pin A, Bagchi A, Biswas G, Fresu LG. Design, synthesis and biological evaluation of vortioxetine derivatives as new COX-1/2 inhibitors in human monocytes. Bioorg Med Chem 2020;28:115760. [PMID: 32992247 DOI: 10.1016/j.bmc.2020.115760] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Ayyash A, Holloway AC. Fluoxetine-induced hepatic lipid accumulation is mediated by prostaglandin endoperoxide synthase 1 and is linked to elevated 15-deoxy-Δ12,14 PGJ2. J Appl Toxicol 2021. [PMID: 34897744 DOI: 10.1002/jat.4272] [Reference Citation Analysis]
2 De Diego-Adeliño J, Crespo JM, Mora F, Neyra A, Iborra P, Gutiérrez-Rojas L, Salonia SF. Vortioxetine in major depressive disorder: from mechanisms of action to clinical studies. An updated review. Expert Opin Drug Saf 2021;:1-18. [PMID: 34964415 DOI: 10.1080/14740338.2022.2019705] [Reference Citation Analysis]
3 Bian M, Ma QQ, Wu Y, Du HH, Guo-Hua G. Small molecule compounds with good anti-inflammatory activity reported in the literature from 01/2009 to 05/2021: a review. J Enzyme Inhib Med Chem 2021;36:2139-59. [PMID: 34628990 DOI: 10.1080/14756366.2021.1984903] [Reference Citation Analysis]
4 Fourrier C, Baune BT. Null effect of vortioxetine augmentation with celecoxib should not be generalized to other antidepressants - Author's reply. Eur Neuropsychopharmacol 2021;55:110-1. [PMID: 34879305 DOI: 10.1016/j.euroneuro.2021.11.002] [Reference Citation Analysis]
5 Baune BT, Sampson E, Louise J, Hori H, Schubert KO, Clark SR, Mills NT, Fourrier C. No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial. Eur Neuropsychopharmacol 2021;53:34-46. [PMID: 34375789 DOI: 10.1016/j.euroneuro.2021.07.092] [Reference Citation Analysis]
6 Strumila R, Lengvenyte A, Olie E, Courtet P, Guillaume S. Null effect of vortioxetine augmentation with celecoxib should not be generalized to other antidepressants. Eur Neuropsychopharmacol 2021;55:84-5. [PMID: 34826785 DOI: 10.1016/j.euroneuro.2021.11.001] [Reference Citation Analysis]